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Recommended by Jakob Izbicki
Pyloric preservation (PP) can frequently be performed at the time of pancreatoduodenectomy (PD), although some reports have
linked it to inferior outcomes such as delayed gastric emptying (DGE). We reviewed records in a single-surgeon practice to assess
outcomes after PD with or without PP. There were 133PDs with 67PPPDs and 66PDs. Diﬀerences between PPPD and PD groups
included cancer frequency, tumor size, OR time, blood loss, and transfusion rate. However, postoperative morbidity rate and
grade, NG tube duration, NGT reinsertion rate, DGE, and length of stay were similar. There was no diﬀerence among patients
with pancreatic cancer. No detrimental outcomes are associated with pyloric preservation during PD. Greater intraoperative ease
and superior survival in the PPPD group are due to confounding, tumor-related variables in this nonrandomized comparison.
Nevertheless, we intend to continue the use of PP with our technique in patients who meet the stated criteria.
Copyright © 2008 Sean P. Dineen et al.ThisisanopenaccessarticledistributedundertheCreativeCommonsAttributionLicense,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. BACKGROUND
Pancreatic cancer continues to carry a dismal prognosis
with a 5-year survival of approximately ﬁve percent [1].
For patients that present with resectable disease, pancre-
atoduodenectomy (PD) oﬀers the best chance for cure
among otherwise poor treatment options [2]. The standard
PD, or Whipple-Kausch operation, involves resection of
the head of the pancreas, duodenum, common bile duct,
gallbladder, and distal stomach including the pylorus. A
gastrojejunostomy restores GI continuity to the stomach.
However, there is debate regarding the necessary extent of
resection. In the 1970s, Traverso and Longmire popularized
a pylorus-preserving pancreatoduodenectomy, initially for
chronic pancreatitis [3]; interestingly, both initial PDs by
Kausch in 1909 and Whipple in 1934 involved preservation
oftheantrumandpylorus.Apylorus-preserving PD(PPPD)
is similar to the “classic” or standard PD except that the
distal stomach and pylorus are left intact and continuity
is restored through a duodenojejunostomy. The rationale
for this modiﬁcation is that it may allow for normal long-
term gastric function, with a controlled release of gastric
contents and a reduced gastric accumulation of small bowel
succus. However, there are some reports indicating that
this technique may generate postoperative challenges due
to delayed gastric emptying (DGE) [4–7]. Additionally,
there are concerns about the adequacy of margins for
cancer operations in which the pylorus is preserved [8].
Prospective randomized trials [6, 9–11], three meta-analyses
[8, 12, 13], and an extensive literature review [7]h a v en o t
led to uniformly congruent or ﬁrm conclusions whether
PPPD has beneﬁcial or adverse eﬀects, although most larger
trials and the more recent pooled analyses have failed
to show that an increased frequency of DGE is clearly
associated with PPPD. The reasons for a lack of clear
interpretability of outcome diﬀerences between PD and
PPPDinsomerandomizedcontrolledtrialsarelackofpower
and confounding factors aﬀecting the outcomes of interest.
For instance, Lin et al. randomized 36 patients and were
able to compare 19 PDs to 14 PPPDs; the only obvious
diﬀerence was a delayed gastric emptying in 1 of 19 PD
patients, and 6 of 14 individuals after PPPD [14]. Yeo et al.
performed a large, single institution trial of 146 “standard”
locoregional pancreatic head resections (with an 86% PPPD
rate), compared to 148 radical PDs without PP, but with
extendedlymphadenectomyandperivascularmesentericsoft2 HPB Surgery
(a) Appearance prior to dissection. The arrow
marks the course of right gastric artery, right
gastric vein, and pyloric vagal branches
(b) Findings after duodenal transection. The
arrow marks the preserved neurovascular struc-
tures
Figure 1: Preservation of the right gastric vasculature and pyloric vagal innervation.
tissue dissection; the groups were well balanced regarding
tumor type, stage, and operative ﬁndings, but the resulting
complication rate, delayed gastric emptying, and hospital
stay were all signiﬁcantly higher in the radical dissection
group and therefore not attributable to any PPPD per se
[10]. The purpose of the current study was to analyze our
clinical experience with PPPD compared to standard PD
based on indications and clinical outcomes, as all procedures
followed the same regional and retroperitoneal soft tissue
dissection strategy, and the PP with subsequent duodenal
anastomosis was the only diﬀerent component between the
two techniques.
2. PATIENTS AND METHODS
Clinical, operative, and pathologic information had been
prospectively collected. The database contains information
from patients treated by a single surgeon in an academic
tertiary care practice setting. Patients were included over a
ten-year period from 1997 to 2007. All 133 individuals pre-
sented with either a head of pancreas or other periampullary
malignancy that was biopsy proven, or had suspicious
ﬁndings for malignancy within a mass lesion, complex cystic
lesion, or ductal stricture aﬀecting the periampullary tissues.
Allpatientshadundergonepreoperativeclinicalandimaging
evaluation; the latter included computed tomography for all,
and magnetic resonance imaging, endoscopic ultrasound, or
endoscopic retrograde cholangiopancreatography as deemed
indicated. Based on this preoperative evaluation, all patients
were considered suitable candidates for partial pancre-
atoduodenectomy. Preoperative biliary decompression for
jaundiced patients was not routinely requested, but was
in place in the majority of patients prior to any surgical
consultation or operative planning.
PPPD was performed whenever deemed safe and feasi-
ble, based on the intraoperative assessment. This included
examination of the mobility of the pyloric ring to exclude
inﬂammatory or neoplastic involvement with the resection
specimen. The presence of suspicious perigastric lymph
nodes, prohibitive for a PPPD, was examined. Normal
anatomy of the distal stomach was ascertained, and patients
with known preoperative gastric motility disorders were also
excluded from PPPD. Finally, an assessment of whether the
pyloric vagal innervation alongside the right gastric vascula-
ture could be preserved was made prior to committing to a
PPPD, as sacriﬁcing this structure may contribute to delayed
gastric emptying. The technique we employ for PPPD is
modiﬁed in a sense that the right gastric artery is preserved
whenever possible, and regarding the consistent use of our
preferred anastomotic technique. Figure 1 illustrates the
distal stomach and pylorus of a typical patient and the tissue
bridge that remains after the resection described. Figure 2
shows the duodenojejunostomy, which in every case was a
hand-sewn, dual layer continuous anastomosis in antecolic
position. All gastrojejunostomies in the PD group were
equally furbished in antecolic position. The management
practice with nasogastric tubes (NGTs) changed during the
studyinterval;duringtheﬁrstﬁveyears,NGTswereroutinely
utilized, and usually removed on postoperative day 1 or 2,
based on the amount of gastric aspirate observed; during
the later half, an orogastric tube was used intraoperatively,
and this was routinely removed at the time of endotracheal
extubation. This practice did not diﬀer between PPPD and
PDpatients.Similarly,placementofajejunostomytookplace
routinely as described [15]; its postoperative use in hospital
and occasional use after discharge did not diﬀer between the
groups.
The deﬁnition of DGE varies among authors, as re-
viewed in detail before [16]; in this study, simple NGT
reinsertion needdidnot automaticallyqualifyforadiagnosis
of delayed gastric emptying. We determined a patient to
have DGE if there was nausea and vomiting requiring
NGT reinsertion for longer than 7 days combined with the
inability to take oral nutrition or hydration by postoperative
day 10, or if the inability to tolerate oral intake prolonged
the patient’s hospital stay by more than 2 days. Patients
requiring NGT placement during critical care support in the
intensive care unit were not included in this group, unless
NGT drainage exceeded 1200mL per 24 hours for greater
than three days. Patients with DGE were also classiﬁed
according to the international study group deﬁnition [16].
All patients with postoperative NGT reinsertion did undergoSean P. Dineen et al. 3
(a) Posterior outer layer completed (b) Posterior inner layer completed (c) All sutures completed
Figure 2: Antecolic duodenojejunostomy, hand-sutured dual-layer technique.
an additional, separate analysis. Postoperative complications
were graded according to the 5-grade scale proposed by
DeOliveiraetal.[17].Pancreaticleakofﬁstulaformationwas
graded according to the international study group deﬁnition
[18]. Postoperative lethal events included those occurring
during the in-hospital stay or within 30 days after the
procedure, whichever came last.
Continuous data between the PD and PPPD groups
were compared via student’s t-test or Mann-Whitney anal-
ysis, based on the original data distribution. Chi square
contingency testing was employed for categorical data.
Survival data were analyzed with nonparametric Kaplan-
Meier statistics; for group diﬀerences, a log-rank test was
performed. Length of NGT duration and length of hospital
stay comparison involved a nonparametric product-limit
method as utilized earlier [19]. In-hospital deaths were
excluded from this analysis, and group comparisons were
performed with a Peto-Peto-Wilcoxon test. All calculations
were performed using StatView software for Macintosh,
version 5.0.1 (SAS Institute Inc., Cary, NC). Statistical
signiﬁcance of group diﬀerences was assumed at a P value
of <.05.
3. RESULTS
3.1. Patientdemographics
Between 1997 and 2007, 133 of 184 pancreatic resections
involved a PD (72%); total pancreatectomies were not
included in this analysis. There were 78 women (59%) and
55 men (41%), with a median age of 66 years (range: 38–87).
The underlying disease mechanisms providing an indication
for resection included 110 malignant processes (83%) and
23 benign disorders (17%). PPPDs (n = 67) and PDs without
PP (n = 66) were numerically balanced. Aside from a slight
diﬀerence in the frequency of a malignant diagnosis and the
primary tumor size, PPPD and PD groups were comparable
regarding demographic and clinicopathologic parameters
(Table 1). Although the distribution of cancer types did not
diﬀerbetweenthetwogroupsinastatisticallysigniﬁcantway,
the higher percentage of pancreatic primaries and a greater
number of cancers in general in the PD group reﬂect greater
oncologic challenges here than those in patients undergoing
PPPD.
3.2. Operativetreatment
The median total operation time for the entire cohort was
6.4 hours, the median estimated blood loss 527mL, and the
overall red blood cell transfusion rate 23%. Several intra-
operative parameters diﬀered between the PPPD and PD
groups. This included total operative time, estimated blood
loss, the amount of intravenous ﬂuid administered, and
the blood transfusion rate (Table 2). In all these categories,
numbers were more favorable in the PPPD group. However,
there were no diﬀerences regarding number of units of
packed red blood cells transfused per patient transfused, or
in the intraoperative urine production.
3.3. Postoperativein-hospitaloutcome
The postoperative overall complication rate was 39%, with
a 14% rate of grade 3 or greater severity that required
either interventional radiologic, operative, or intensive care
management. Fifteen patients experienced a postoperative
pancreatic or biliary leak (11%); the leak severity included
grade A (n = 3, 20%), grade B (n = 3, 20%), and grade
C( n = 9, 60%). There were six postoperative lethal events,
for an overall mortality rate of 4.5%. As shown in Table 3,
there were no obvious group diﬀerences in postoperative
morbidity, leak rate or mortality. The median NGT duration
for all patients was 1 day. In 19% of patients, the NGT had
to be replaced at least once during the postoperative course.
However, DGE as deﬁned was observed in only two patients
after PPPD, and in three patients past PD. DGE according
to the international study group deﬁnition included was
observed in eight patients (6%), and included grades A (n =
5), B (n = 1), and C (n = 2). Two of the individuals with DGE
had a grade B pancreatic leak. In none of these parameters
were diﬀerences detected between the PD and PPPD groups
(Table 3). One patient with DGE after PPPD had a biliary
leak, the other had no other identiﬁable accompanying
morbidity event. The median length of stay was 10 days
overall. As depicted in Figure 3, the cumulative length of stay4 HPB Surgery
Table 1: Demographic and pathologic data.
Demographic Total cohort PPPD PD P value
Patients (n) 133 67 66 N/A
Gender (%) Female 59 66 52 NS
Male 41 34 48
Age, median (range) (years) 66 (39–88) 66 (45–88) 66 (39–86) NS
ASA group 3 or greater (%) 59 59 60 NS
Diagnostic group (%) Malignant 83 76 89 .04
Benign 17 24 11
Cancer type (% of patients with cancer)
Pancreatic 64 56 72
NS Ampullary 17 25 11
Other 18 19 17
Tumor size, mean (cm) 3.1 3.8 3.5 .01
T3+ (%) 74 73 75 NS
N pos. (%) 62 55 68 NS
Grade 3+ 82 84 78 NS
Total LN count, mean (n) 14.3 13.4 15.3 NS
R0 rate (%) 77 83 71 NS
Table 2: Operative treatment characteristics.
Total cohort (n = 133) PPPD (n = 67) PD (n = 66) P value
OR time (hour) 6.4 5.8 7 <.0001
EBL (mL) 527 413 636 .006
IVF (mL) 7381 6768 7954 .02
Transfusion rate (%) 23 13 33 .007
Units PRBC, mean 0.56 0.45 0.76 NS
Units PRBC per transfused patient (n) 2.2 2.2 2.2 NS
Urine output per hour operating time, mean (mL) 141 173 118 NS
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Figure 3: Length of hospital stay, by resection group.
comparison did not reveal signiﬁcant diﬀerences between
the treatment groups, and the subset of patients with a
prolonged hospital stay was similar in the PD and PPPD
cohorts.
3.4. Survival
At a median follow-up of 15 months (20 for survivors), the
overall actuarial survival is statistically superior in the PPPD
group compared to PD patients by univariate analysis; the
median survival time was 26 months after PPPD, and 16
months after PD (P = .03, Figure 4(a)). This certainly is
confounded by the higher percentage of cancer, a greater
frequency of pancreatic cancer, and a larger tumor size in
the PD group. Consequently, the overall survival for cancer
patients only (Figure 4(b)), or for individuals speciﬁcally
with pancreatic cancer (Figure 4(c)) was not statistically
diﬀerent between the two- procedure groups.
4. DISCUSSION
In this series of 133 patients undergoing pancreatoduo-
denectomy within a single-surgeon practice, PPPD has
been performed with constant criteria of intraoperative
assessment, preservation of pyloric vagal innervation, and
a duodenal lumen-protective anastomotic technique with
dual-layer absorbable suture material. In addition, all duo-
denojejunostomies and gastrojejunostomies were placed asSean P. Dineen et al. 5
Table 3: Postoperative outcomes.
Total cohort (n = 133) PPPD (n = 67) PD (n = 66) P value
Morbidity (%) 39 39 40 NS
Grade 3+ morbidity (%) 14 13 14 NS
Pancreatic leak (%) 11 12 11 NS
Lethal events (n)6 2 4 N S
Median NGT duration (days) 1 1 2 NS
NGT reinsertion (%) 19 21 17 NS
Delayed gastric emptying (%) 3.8 3.0 4.5 NS
Delayed gastric emptying, international study group deﬁnition (%) 6.0 6.0 6.1 NS
Length of stay, median (d) 10 10 10 NS
antecolic anastomoses. Our analysis of these prospectively
collected data shows no obvious detriments to the use
of PPPD, but also fails to show clear beneﬁts. A PP
procedure had been performed in half of the patients; it was
associated with less complex operations based on reduced
operative time, less intraoperative blood loss and fewer
transfusions. However, there were no outcome diﬀerences
between PD and PPPD groups regarding length of stay or
cancer-speciﬁc survival. These apparent diﬀerences between
the two procedures need to be interpreted thoughtfully,
because some adverse clinicopathologic features appear to
predispose a patient to the PD group. Importantly, there
was no evidence to suggest that PPPDs are associated with
a higher rate of postoperative delayed gastric emptying,
or a greater NGT reinsertion need. Overall, the rate of
DGE appears low in this series in both groups, and with
the stated criteria for performing a PPPD, the outcomes
relating to DGE shown here would certainly support
its use.
The results of our study are consistent with larger
randomized controlled trials and meta-analyses comparing
intraoperative and postoperative outcomes between PPPD
and PD.Ourobserved PPPD-associatedreduction in average
total operative time by 1.2 hours, in mean estimated blood
loss by 223mL, in transfusion rate by 20%, and in average
PRBC number transfused by 0.31 generally correspond to
numbers in part reported by others [8, 12, 13]. While it has
to be remembered that these meta-analyses are largely based
on the same trials, some of these randomized trials support
similar intraoperative beneﬁts of PPPD [9, 14] while others
do not [11]. While the reduced operative time is intuitive, it
is not sensible to assume that the mere addition of a distal
gastrectomy should lead to signiﬁcantly larger blood loss,
transfusion rate, and possibly margin positivity. In our non-
randomized series, these ﬁndings are best explained with the
higherpercentageofpancreaticcancercasesinthePDgroup,
where more challenging dissections tend to be encountered
at the mesenteric vasculature. In our experience, this is
the technical component that governs blood loss as well as
margin status. When subgroups are well balanced regarding
pancreaticversusotherperiampullarycancers,nodiﬀerences
in blood loss, and a comparable low R1 rate have been
reported [10].
DGE is a concern that has been raised repeatedly in
conjunction with the pylorus preserving procedure [4, 14,
20]. The cause of DGE is uncertain, and may involve factors
that are either speciﬁc to the PP technique, or common to
bothPPPDandPDsuchasthelossofpancreaticpolypeptide
production associated with pancreatic head resection [7].
Experimentalevidencesuggeststhatpreservationoftheright
gastric artery and the neurovascular bundle supplying the
pylorus are critical to avoid DGE [21]. Our preferred tech-
nique of PPPD makes a strong attempt to preserve the right
gastric artery and the tissue containing the pyloric branch of
the vagus nerve, and we feel this may indeed contribute to
the low rate of DGE in our study. Other factors speciﬁc to a
PP approach may relate to technical aspects of the duodenal
anastomosis, as this may easily be rendered too narrow
throughconventionalstaplingtechniques.Interestingly,both
patients in our series with DGE after PPPD had widely
patent anastomoses, too, as documented via unimpaired
radiographic emptying of intragastric contrast. This would
rather suggest a functional disturbance of gastric motility
than an anatomic obstacle, if DGE is still encountered
after using the technique described. An antecolic duodenal
reconstruction may be an important determinant to reduce
the risk for DGE. As reported by Hartel et al., in a series
of 100 patients undergoing PPPD, DGE occurred with
signiﬁcantly greater frequency after retrocolic anastomoses
thanantecolicreconstructions[22].Thisnotionissupported
by a recent randomized prospective trial with 40 patients,
although the resulting NGT duration of 4 versus 19 days,
and the hospital stay of 28 versus 48 days are not applicable
to a Western patient series [23]. A prospective evaluation of
50 patients with antecolic PPPD had demonstrated a DGE
rate of 12%, higher than in our experience, but based on
ad i ﬀerent deﬁnition [24]. Importantly, DGE under these
conditions was linked to the presence of other postoperative
complications, including pancreatic leaks. Thus, the position
of the duodenal anastomosis in relation to the transverse
colon apparently is more important in determining DGE
than how the pancreatic reconstruction is being performed
[25]. Finally, DGE may be induced by a disturbance in
intestinal splanchnic innervation after more radical resec-
tions, as suggested by a higher DGE rate after PD with
extended retroperitoneal dissection compared to the lesser6 HPB Surgery
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(c) Overall survival, pancreatic cancer patients only
Figure 4: Overall actuarial survival, by resection group.
dissection group with a high PPPD number [10]. We do
not perform a circumferential dissection of the superior
mesenteric artery to avoid such morbidity.
Operative radicality in oncologic terms does not seem
to be negatively aﬀected by performing PPPDs. While a
minimum number of 10 to 15 lymph nodes has been
suggested to optimize staging accuracy and associated sur-
vival for both pancreatic and other periampullary cancers
[26, 27], more radical resections have failed to improve
survival of pancreatic cancer [10, 28, 29]. As our ﬁndings
regarding lymph node counts suggest, this “radicality” is
not aﬀected by the PPPD modiﬁcation. Positive margin
resection is a powerful predictor for increased survival
hazards, which also does not seem to be inﬂuenced by
the performance of a PP [30]. In our series, the R0
resection rate was higher after PPPD, reﬂecting the fact
that more aggressive malignancies with greater risks for
radial margin involvement tend to require resection of
antrum and pylorus based on intraoperative assessment. In
this context, it should also be noted that volume-outcome
relationships regarding both early postoperative mortality
and long-term survival have been well demonstrated for
pancreatic cancer, and that “standard” results as pertaining
to PP procedures have to be carefully judged under these
aspects as well [31, 32]. Virtually, all reports on PPPD and
PD comparisons reﬂecthigh-volume institutions and cannot
easily be translated into low-volume settings. Comparable
morbidity and survival between PPPD and PD as seen in
our results and those of others [11, 33] suggest that the
standard PD is certainly an acceptable procedure for the
treatment of periampullary malignancies. Subtle implica-
tions such as the possible need for continued medication to
control gastric acid after PP (which we do not use) would
easily sway our perceived balance in favor of a PD with
antrectomy.
In conclusion, we report that PPPD is as eﬀective as PD
in resections for pancreatic or other periampullary cancers,
provided the pylorus itself and the surrounding soft tissues
are free from disease. Intraoperative advantages to PPPD are
confounded in this series, but still of potential relevance. An
oncologically appropriate procedure with acceptable early
and late postoperative outcomes can be achieved with our
PPPD approach. Although it remains uncertain whether
pyloric vagal preservation, duodenal anastomotic technique,
or antecolic reconstruction contribute decisively to the low
rate of postoperative DGE and other morbidity events, we
plan to continue their use within the described technique
whenever judicious pre- and intra-operative assessment
based on individual patient and disease factors supports a
PPPD indication.
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